Benefits and harms of extending the duration of dual antiplatelet therapy after percutaneous coronary intervention with drug-eluting stents:a meta-analysis

Kwok, Chun Shing, Bulluck, Heerajnarain, Ryding, Alisdair D and Loke, Yoon K (2014) Benefits and harms of extending the duration of dual antiplatelet therapy after percutaneous coronary intervention with drug-eluting stents:a meta-analysis. The Scientific World Journal, 2014.

Full text not available from this repository. (Request a copy)

Abstract

The optimal duration of dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI) is unclear.

Item Type: Article
Faculty \ School: Faculty of Medicine and Health Sciences > Norwich Medical School
Depositing User: Pure Connector
Date Deposited: 07 Jul 2014 13:14
Last Modified: 21 Apr 2020 23:07
URI: https://ueaeprints.uea.ac.uk/id/eprint/48916
DOI: 10.1155/2014/794078

Actions (login required)

View Item View Item